Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Paclitaxel-Induced Neuropathy in Breast Cancer
NCT05966441Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Aug 2023
- Primary completion
- Dec 2023
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Ain Shams University. Primary endpoints: Incidence and severity of paclitaxel-induced peripheral neuropathy at 3 months and Damage of nerve fibers induced by paclitaxel at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT05966441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05966441.